[Role of prostaglandin analog in eradication of Helicobacter pylori].
Tominaga
Kazunari
K
Department of Gastroenterology, Osaka City University Graduate Medical School.
Higuchi
Kazuhide
K
Watanabe
Toshio
T
Uchida
Toshiyuki
T
Fujiwara
Yasuhiro
Y
Arakawa
Tetsuo
T
D000527:Alprostadil / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016207:Cytokines / Q000502:physiology; D015232:Dinoprostone / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination; D016620:Enprostil / Q000494:pharmacology / Q000627:therapeutic use; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D016595:Misoprostol / Q000494:pharmacology / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D055502:Secondary Prevention
D000897:Anti-Ulcer Agents; D016207:Cytokines; D016595:Misoprostol; D000527:Alprostadil; C045125:ornoprostil; D016620:Enprostil; D015232:Dinoprostone